Allogeneic cell therapies
The company advances allogeneic cell therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Poseida is a clinical-stage biopharmaceutical company advancing allogeneic cell therapies and genetic medicines.
Poseida was acquired by Roche in early 2025 and is now part of the Roche Group.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company advances allogeneic cell therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
The company advances genetic medicines.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 11, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 11, 2026, September 14, 2026, September 15, 2026, September 17, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 21, 2026, September 26, 2026, September 27, 2026, September 30, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.